Abstract
Minocycline has been thought to induce “black thyroid”, a condition marked by discoloration due to brown deposits. However, its effect on thyroid function in humans is still obscure. We conducted a prospective study of thyroid hormone levels in 17 patients who were administered 200 mg minocycline daily for 10 days. We found that minocycline significantly reduced the serum total thyroxine level (8.43±0.61 to 7.09±0.45 μg/dl, mean ± SEM;P<0.01), and free thyroxine level (1.12±0.10 to 1.01±0.08 ng/dl, mean ± SEM;P<0.01). There was also a slight, but insignificant, elevation of thyroid stimulating hormone (TSH) in patients treated with minocycline. Similar suppression of thyroxine and free thyroxine was not observed in control patients treated with β-lactam and/or aminoglycoside antibiotics. Risk factors for the reduction in these thyroxine levels included age and a high serum baseline level of free thyroxine. We found a significant correlation between the free baseline thyroxine level and a reduction in free thyroxine after minocycline administration (Y=0.420X−0.377, r=0.597;P<0.01). Despite the observed alterations, the serum levels of all thyroid hormones after minocycline therapy were still within the normal range. This antibiotic does not appear to induce clinical hypothyroidism, yet given the results of this study, we would like to recommend pituitary-thyroid axis monitoring during the use of this antibiotic.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Attwood HD, Dennett X. A black thyroid and minocycline treatment. BMJ 1976;2:1109–1110.
Saul SH, Dekker A, Lee RE, et al. The black thyroid. Its relation to minocycline use in man. Arch Pathol Lab Med 1983;107:173–177.
Gordon G, Sparano BM, Kramer AW, et al. Thyroid gland pigmentation andminocycline therapy. Am J Pathol 1984;117:98–109.
Hanzlick R, Wilson R. Minocycline-related black thyroid. Am J Forensic Med Pathol 1988;9:200–202.
Reid JD. The black thyroid associated with minocycline therapy. A local manifestation of a drug-induced lysosome/substrate disorder. Am J Clin Pathol 1983;79:738–746.
Senba M, Toda Y, Yamashita H. Black thyroid associated with minocycline therapy: histochemical and ultrastructural studies on the brown pigment. Isr J Med Sci 1988;24:51–53.
Enochs W S, Nilges MJ, Swartz HM. The minocyclineinduced thyroid pigment and several synthetic models; identification and characterization by electron paramagnetic resonance spectroscopy. J Pharmacol Exp Ther 1993;266:1164–1176.
Tajima K, Miyagawa J, Nakajima H, et al. Morphological and biochemical studies on minocycline-induced black thyroid in rats. Toxicol Appl Pharmacol 1985;81:393–400.
Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: the “euthyroid sick syndrome”, Endocr Rev 1982;3:164–217.
Gambert SR, Tsitouras PD. Effect of age on thyroid hormone physiology and function. J Am Geriatr Soc 1985;33:360–365.
Gregerman RI, Gaffney GW, Shock NW. Thyroxine turnover in euthyroid man with special reference to changes with age. J Clin Invest 1962;41:2065–2072.
Hansen JM, Skovsted L, Siersbaek-Nielsen K. Age-dependent changes in iodine metabolism and thyroid function. Acta Endocrinol 1975;79:60–65.
Kaptein EM, Fisler JS, Duda MJ, et al. Relationship between the changes in serum thyroid hormone levels and protein status during prolonged protein supplemented caloric deprivation. Clin Endocrinol 1985;22:1–15.
Kaptein EM, Feinstein EI, Massry SG. Thyroid hormone metabolism in renal failure. Contrib Nephrol 1982;33:122–135.
Kelly RG, Kanegis LA. Metabolism and tissue distribution of radioisotopically labeled minocycline. Toxicol Appl Pharmacol 1967;11:171–183.
Overturf, GD. Bacterial meningitis-therapy. In: Hoeprich PD, Jordan MC, Ronald AR (eds) Infectious disease: a treatise of infectious processes. Philadelphia: JB Lippincott Company, 1994; 1116–1121.
Saito K, Jujio T, Hashizume I, et al. Studies on goitrogenic action of minocycline and related compound in the rat. Jpn J Antibiot 1971;24:265–271.
Dunn JT. Thyroglobulin. Chemistry and biosynthesis. In: Braverman LE, Utiger RD (eds) Werner and Ingbar's The Thyroid. Philadelphia: JB Lippincott Company, 1991; 98–126.
Benitz KF, Roberts GKS, Yasu A. Morphologic effects of minocycline in laboratory animals. Toxicol Appl Pharmacol 1967;11:150–170.
Matsubara F, Mizukami Y, Tanaka Y. Black thyroid: morphological, biochemical and geriatric studies on the brown granules in the thyroid follicular cells. Acta Pathol Jpn 1982;32:13–22.
Alexander CB, Herrera GA, Jaffe K, et al., Black thyroid: clinical manifestations, ultrastructural findings, and possible mechanisms. Hum Pathol 1985;16:72–78.
Author information
Authors and Affiliations
About this article
Cite this article
Shigematsu, T., Matsumoto, F., Imai, T. et al. Suppressive effects of minocycline on the pituitary-thyroid axis in humans. J Infect Chemother 1, 116–121 (1995). https://doi.org/10.1007/BF02348755
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02348755